Mitosis. © By Mysid - Vectorized in CorelDraw by Mysid / https://commons.wikimedia.org/w/index.php?curid=1414818

Researchers unravel potential cancer target

British researchers have found out what’s going wrong with chromosome segregation in some cancers. 

Read more
© Pharming

Pharming licenses orphan drug from Novartis

Pharming NV has paid €17.9m upfront to Novartis AG for an exclusive license to CDZ173, a late stage drug for the treatment of APDS
Read more
Group of mesenchymal (green) stem cells migrating in a tooth to further regenerate tissues. © Media and Communications | University of Plymouth

New stem cell population may help repair teeth

Researchers have discovered that crosstalk of a newly discovered stem cell population with quiescent stem cells may help repair teeth in the future.

Read more
iPSCs derived from somatic cells through a novel reprogramming method. © UCLA Broad Stem Cell Research Center/Plath Lab

Bayer bags iPSC specialist BlueRock Therapeutics

Bayer has widened its pipeline in neurology, cardiology, and immunology by acquiring induced pluripotent stem cell specialist BlueRock Therapeutics.

Read more
Circulating tumor DNA (ctDNA) is found in serum and plasma fractions from blood. The exact mechanism of ctDNA release is unknown. Once ctDNA is isolated, it can be sequenced for mutational analysis. © Creative commons licence, RachelJuneWong

Liquid biopsy identifies residual breast cancer

Using a platform tailored to patients’ specific cancer mutations, British and US researchers for the first time detected residual disease in breast cancer patients.

Read more

Immunic appoints Sanjay S. Patel as CFO

Immunic, Inc., a clinical-stage biopharmaceutical company focused on developing potentially best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced the appointment of Sanjay S. Patel, CFA, as Chief Financial Officer, effective July 15, 2019. Mr. Patel replaces Tamara A. Seymour, who has served as the company’s Interim Chief Financial Officer since April 26, 2019.

Read more
Waste carbon streams as resources for Lanzatech's process. © Lanzatech

Novo Holdings puts $72m in Lanzatech

Novo Holdings A/S (Novo Holdings) invests $72m in LanzaTech to support development of the company’s sustainable fuels and chemicals platform
Read more
With the "BigStitcher" software you can reconstruct a sample and then rotate and turn it virtually, get an overview of the big picture or zoom into individual structures. This works both as a user, as illustrated here, and as an algorithm that analyzes the data and cannot load the entire image into RAM. Neurons expressing a specific gene are marked in green. Such data now make it possible for the first time to systematically characterize differences at the single-cell level between normal and genetically modified mice and to draw conclusions about potential behavioral changes that may result. © Preibisch Lab / Treier Lab, MDC

Google maps for tumours and organs

German researchers have developed a software that allows to manage and correct the huge amount of data generated by 3D reconstruction of tumours or organs using light sheet microscopy.
Read more
Vaccinia virus. © wikipedia/commons PHIL

Transgene’s licenced oncolytic virus fails in Phase III

SillaJen, the licensor for French immunoncology specialist Transgene SA, has stopped enrolment into the Phase III Phocus trial after an Independent Data Review Comittee predicted the study endpoint won’t be met.

Read more

Pieris Pharmaceuticals appoints Dr. Maya Said

Pieris Pharmaceuticals, Inc. today announced that Maya R. Said, Sc.D., has joined the Company’s Board of Directors.

Read more